$3.70
0.030.82%
Ult. Agg.: Nov 2, 5:29 PM
Opus Genetics (IRD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.16 | $-0.14 | $-0.10 | $-0.13 |
| Actual | $-0.14 | $-0.75 | $-0.21 | $-0.25 |
| Surprise | +12.5% | -435.7% | -110.0% | -92.3% |
| Revenue | ||||
| Estimate | $2.7M | $2.9M | $2.9M | $3.0M |
| Actual | $755000 | $2.2M | $3.9M | $3.1M |
| Surprise | -71.6% | -25.8% | +31.4% | +4.09% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.15 | $-0.04 | $-0.20 | $-0.21 |
| Revenue | ||||
| Consensus | $2.1M | $8.3M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.14 | $-0.16 | 12.5 % |
| Q1 | May 12, 2026 | $-0.75 | $-0.14 | -435.7 % |
| Q4 | Mar 10, 2026 | $-0.21 | $-0.10 | -110.0 % |
| Q3 | Nov 12, 2025 | $-0.25 | $-0.13 | -92.3 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $755.00K | $2.66M | -71.6 % |
| Q1 | May 12, 2026 | $2.16M | $2.91M | -25.8 % |
| Q4 | Mar 10, 2026 | $3.87M | $2.94M | 31.4 % |
| Q3 | Nov 12, 2025 | $3.08M | $2.96M | 4.09 % |